合肥創新(xin)醫藥(yao)(yao)技術有(you)限(xian)公(gong)(gong)司(si)(簡稱(cheng):公(gong)(gong)司(si)、創新(xin)醫藥(yao)(yao))2001年(nian)成立,是(shi)安(an)徽(hui)省(sheng)科技廳(ting)認定的科研(yan)(yan)(yan)單(dan)位,安(an)徽(hui)省(sheng)新(xin)型(xing)研(yan)(yan)(yan)發(fa)(fa)機(ji)構。公(gong)(gong)司(si)一(yi)(yi)直持(chi)(chi)續專注(zhu)中(zhong)西新(xin)藥(yao)(yao)研(yan)(yan)(yan)發(fa)(fa)、服務;2018年(nian)以來,戰(zhan)略布局創新(xin)MAH持(chi)(chi)有(you)人品(pin)種研(yan)(yan)(yan)發(fa)(fa),搶(qiang)仿市場緊缺化藥(yao)(yao)特(te)色品(pin)種,通過挖掘療效突(tu)出的中(zhong)藥(yao)(yao)經典(dian)名(ming)方(fang)和同(tong)(tong)名(ming)同(tong)(tong)方(fang),加大自主產(chan)權創新(xin)藥(yao)(yao)的研(yan)(yan)(yan)發(fa)(fa),發(fa)(fa)展為(wei)中(zhong)西新(xin)藥(yao)(yao)研(yan)(yan)(yan)發(fa)(fa)、臨床、生(sheng)產(chan)、銷售一(yi)(yi)體化商(shang)業模式(shi)。
目前,公司研發(fa)和儲備了大量(liang)自主(zhu)(zhu)產權(quan)的中藥創新(xin)(xin)(xin)品種(創新(xin)(xin)(xin)1類),在(zai)我國中藥正在(zai)迎(ying)來大好的發(fa)展機遇下,將(jiang)成為具潛力(li)和特色的自主(zhu)(zhu)創新(xin)(xin)(xin)型(xing)醫藥企業,2023年實現(xian)國內外IPO。